AN EARLY CLINICAL TRIAL OF OXAPROTILINE IN HOSPITALIZED PATIENTS WITH PRIMARY DEPRESSIONFEIGHNER JP; ROFFMAN M; DIXON RB et al.1981; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1981; VOL. 29; NO 3; PP. 363-369; BIBL. 6 REF.Article

The effects of single and repeated doses of maprotiline, oxaprotiline and its enantiomers on foot-shock induced fighting in ratsMOGILNICKA, E; BOISSARD, C. G; WALDMEIER, P. C et al.Pharmacology, biochemistry and behavior. 1983, Vol 19, Num 4, pp 719-723, issn 0091-3057Article

A DOUBLE-BLIND COMPARATIVE STUDY OF OXAPROTILINE WITH AMITRIPTYLINE AND PLACEBO IN MODERATE DEPRESSIONROFFMAN M; GOULD EE; BREWER SJ et al.1982; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1982; VOL. 32; NO 2; PP. 247-256; BIBL. 4 REF.Article

The metabolic fate of [¹⁴C] oxaprotiline•HCl in man. II: Isolation and identification of metabolitesDIETERLE, W; FAIGLE, J. W; KRIEMLER, H.-P et al.Xenobiotica (London. Print). 1984, Vol 14, Num 4, pp 311-319, issn 0049-8254Article

The structure of diastereomeric oxaprotiline metabolites. An NMR studyWINKLER, T; DIETERLE, W; HUG, P et al.Helvetica chimica acta. 1984, Vol 67, Num 8, pp 2082-2086, issn 0018-019XArticle

The metabolic fate of ¹⁴C-oxaprotiline•HC1 in man. III: Stereospecific dispositionDIETERLE, W; FAIGLE, J. W; KUNG, W et al.Biopharmaceutics & drug disposition. 1984, Vol 5, Num 4, pp 377-386, issn 0142-2782Article

The metabolic fate of [¹⁴C] oxaprotiline•HCl in man. I: Disposition and preliminary pharmacokineticsDIETERLE, W; FAIGLE, J. W; IMHOF, P et al.Xenobiotica (London. Print). 1984, Vol 14, Num 4, pp 303-310, issn 0049-8254Article

Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trialSCHMAUSS, M; LAAKMANN, G; DIETERLE, D et al.Pharmacopsychiatry. 1985, Vol 18, Num 4, pp 282-285, issn 0176-3679Article

MULTIPLE INVERSE ISOTOPE DILUTION ASSAY FOR THE STEREOSPECIFIC QUANTITATIVE DETERMINATION OF R(-) AND S(+)-OXAPROTILINE IN BIOLOGICAL FLUIDSDIETERLE W; FAIGLE JW.1982; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1982; VOL. 242; NO 2; PP. 289-297; BIBL. 12 REF.Article

ANTISEROTONINERGIC PROPERTIES OF MAPROTILINE AND A NEW ANTIDEPRESSANT, OXAPROTILINE: TWO SELECTIVE NA UPTAKE INHIBITORSDELINI STULA A; BISCHOFF S; RADEKE E et al.1982; DRUG DEVELOPMENT RESEARCH; ISSN 0272-4391; USA; DA. 1982; VOL. 2; NO 6; PP. 543-550; BIBL. 20 REF.Article

Psychopatologischer und psychophysiologischer Verlauf bei stationären depressiven Patienten unter standardisierter Behandlung mit Clomipramin bzw. Oxaprotilin = Psychopathological and psychophysiological course in depressive inpatients treated with Clomipramine or OxaprotilineSTEINER, B; WOLFERSDORF, M; KELLER, F et al.Schweizer Archiv für Neurologie und Psychiatrie (1985). 1991, Vol 142, Num 3, pp 259-269, issn 0258-7661, 11 p.Article

OXAPROTILINE: INDUCTION OF CENTRAL NORADRENERGIC SUBSENSITIVITY BY ITS (+)-ENANTIOMERMISHRA R; GILLESPIE DD; LOVELL RA et al.1982; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1982; VOL. 30; NO 20; PP. 1747-1755; BIBL. 20 REF.Article

Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients: clinical aspects, psychophysiology, and drug plasma levelsGIEDKE, H; GAERTNER, H; BREYER-PFAFF, U et al.European archives of psychiatry and neurological sciences. 1986, Vol 235, Num 6, pp 329-338, issn 0175-758XArticle

The dexamethasone suppression test and response to placeboPESELOW, E. D; LAUTIN, A; WOLKIN, A et al.Journal of clinical psychopharmacology. 1986, Vol 6, Num 5, pp 286-291, issn 0271-0749Article

The acute and chronic effects of (+) and (-) oxaprotiline upon elatonin secretion in normal subjectsPALAZIDOU, E; SKENE, D; ARENDT, J et al.Psychological medicine (Print). 1992, Vol 22, Num 1, pp 61-67, issn 0033-2917Article

Measurement of maprotiline and oxaprotiline in plasma by high-performance liquid chromatography of fluorescent derivativesBREYER-PFAFF, U; WIATR, R; NILL, K et al.Journal of chromatography. 1984, Vol 309, Num 1, pp 107-114, issn 0021-9673Article

Differential therapy of the depressive syndrome: results of a therapeutic study with fluvoxamine vs. oxaprotilineEMRICH, H. M; BERGER, M; VON ZERSSEN, D et al.Advances in pharmacotherapy. 1986, Vol 2, pp 57-64, issn 0253-2093Article

Clinical studies of the effect of (+) and (-)-oxaprotiline upon noradrenaline uptakeCHECKLEY, S. A; THOMPSON, C; BURTON, S et al.Psychopharmacologia. 1985, Vol 87, Num 1, pp 116-118, issn 0033-3158Article

Synthesis and C-11 labeling of three potent norepinephrine transporter selective ligands ((R)-nisoxetine, lortalamine, and oxaprotiline) for comparative PET studies in baboonsLIN, Kuo-Shyan; DING, Yu-Shin.Bioorganic & medicinal chemistry. 2005, Vol 13, Num 15, pp 4658-4666, issn 0968-0896, 9 p.Article

cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activityPEREZ, J; TINELLI, D; BIANCHI, E et al.Neuropsychopharmacology (New York, NY). 1991, Vol 4, Num 1, pp 57-64, issn 0893-133X, 8 p.Article

Biotransformation of oxaprotiline: isolation and identification of metabolites in urine of rat and dogDIETERLE, W; FAIGLE, J. W; KRLEMLER, H.-P et al.Xenobiotica (London. Print). 1986, Vol 16, Num 8, pp 743-752, issn 0049-8254Article

Oxaprotiline : enantioselective noradrenaline uptake inhibition indicated by intravenous amine pressor tests but not α₂-adrenoceptor binding to intact platelets in manREIMANN, I. W; FIRKUSNY, L; ANTONIN, K. H et al.European journal of clinical pharmacology. 1993, Vol 44, Num 1, pp 93-95, issn 0031-6970Article

The β-adrenoceptor-coupled adenylate cyclase system in rat C6 glioma cells : deamplification by isoproterenol and oxaprotilineMANIER, P. H; BIECK, P. R; DUHL, D. M et al.Neuropsychopharmacology (New York, NY). 1992, Vol 7, Num 2, pp 105-112, issn 0893-133XArticle

La modification des potentiels évoqués lents chez les déprimés sous amitriptyline et oxaprotiline = Slow brain potential changes in depressive patients during antidepressive treatment with amitriptyline or oxaprotilineGIEDKE, H; HEIMANN, H; REIN, W et al.Revue d'électroencéphalographie et de neurophysiologie clinique. 1987, Vol 17, Num 3, pp 279-287, issn 0370-4475Article

Comparative anticholinergic activity of oxaprotiline and amitriptylineROFFMAN, M; GOULD, E; BREWER, S et al.Drug development research. 1983, Vol 3, Num 6, pp 561-566, issn 0272-4391Article